GAINESVILLE, FL – Xhale Inc. has received a $1.8M SBIR Phase II grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the NIH to develop a next generation breath-based ethanol sensor. (more…)
JOHNSON CITY, TN – RxBio Holdings, which has developed a product that protects users against lethal doses of radiation, has raised nearly $122 million from 120 investors for a merger of its two commonly controlled affiliated companies, according to a regulatory filing. (more…)
MORRISVILLE, NC – Medical device company nContact has closed on a $4 million mixed securities offering, according to a regulatory filing. The company makes devices for the minimally invasive treatment of heart arrhythmias. (more…)
TAMPA, FL – Oragenics Inc. (OTCBB:ORNI) has closed on a $2 million equity and debt round, according to a regulatory filing. The company has developed an oral treatment that could prevent tooth cavities for a lifetime, an antibiotic effective against resistant bacteria, and other innovative products.Koski Family Limited Partnership is the company’s main investor. (more…)
CARY, NC - CeNeRx BioPharma Inc., a developer of CNS drugs, has raised $13 million in new Series C funding (including $3m in debt). Return backers include Aisling Capital, L Capital Partners and Pappas Ventures. (more…)
ATLANTA – Emory Vaccine Center at Yerkes National Primate Research Center, Emory University has won a five-year, $15 million National Institutes of Health grant to to study human immune responses to vaccination. (more…)
RESEARCH TRIANGLE PARK, NC – Vaccine developer Medicago USA has won a $21 million Defense Advanced Research Projects Agency grant to develop a 90,000 square foot facility in Research Triangle Park to make vaccines from tobacco plants and virus-like-particles (VLPs). The $42 million project will demonstrate the company’s ability to make 10 million doses of flu vaccine a month.Eventually, the project will create hundreds of jobs. (more…)
